June 2, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549-3720
| Attention: | Michael Clampitt |
Jessica Livingston |
Vanessa Robertson |
David Burton |
| Re: | Applied Molecular Transport Inc. |
Registration Statement on Form S-1 |
(File No. 333-238464) |
Acceleration Request |
| Requested Date: | Thursday, June 4, 2020 |
| Requested Time: | 4:00 P.M. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Applied Molecular Transport Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-238464) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Michael Coke at (650) 565-3596.
[Signature page follows]
| Sincerely, |
| APPLIED MOLECULAR TRANSPORT INC. |
| /s/ Tahir Mahmood, Ph.D. |
| Tahir Mahmood, Ph.D. |
| Co-Founder and Chief Executive Officer |
Enclosures
| cc (w/o enclosures): | John Burwise, Deloitte & Touche LLP |
Angela Vanscoy, Deloitte & Touche, LLP |
Kristin VanderPas, Cooley LLP |
Michael Coke, Wilson Sonsini Goodrich & Rosati, P.C. |
Christina Poulsen, Wilson Sonsini Goodrich & Rosati, P.C. |
